Literature DB >> 16931332

Chemical probes of UDP-galactopyranose mutase.

Erin E Carlson1, John F May, Laura L Kiessling.   

Abstract

Many pathogenic prokaryotes and eukaryotes possess the machinery required to assemble galactofuranose (Galf)-containing glycoconjugates; these glycoconjugates can be critical for virulence or viability. Accordingly, compounds that block Galf incorporation may serve as therapeutic leads or as probes of the function of Galf-containing glycoconjugates. The enzyme UDP-galactopyranose mutase (UGM) is the only known generator of UDP-galactofuranose, the precursor to Galf residues. We previously employed a high-throughput fluorescence polarization assay to investigate the Klebsiella pneumoniae UGM. We demonstrate the generality of this assay by extending it to UGM from Mycobacterium tuberculosis. To identify factors influencing binding, we synthesized a directed library containing a 5-arylidene-2-thioxo-4-thiazolidinone core, a structure possessing features common to ligands for both homologs. Our studies offer a blueprint for identifying inhibitors of the growing family of UGM homologs and provide insight into UGM inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931332     DOI: 10.1016/j.chembiol.2006.06.007

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  34 in total

Review 1.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

2.  Non-carbohydrate inhibitors of the lectin DC-SIGN.

Authors:  M Jack Borrok; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

Review 3.  Controlled microwave heating in modern organic synthesis: highlights from the 2004-2008 literature.

Authors:  C Oliver Kappe; Doris Dallinger
Journal:  Mol Divers       Date:  2009-04-21       Impact factor: 2.943

4.  UDP-galactopyranose mutases from Leishmania species that cause visceral and cutaneous leishmaniasis.

Authors:  Isabel O Fonseca; Karina Kizjakina; Pablo Sobrado
Journal:  Arch Biochem Biophys       Date:  2013-09-03       Impact factor: 4.013

5.  High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.

Authors:  Subramaniam Ananthan; Ellen R Faaleolea; Robert C Goldman; Judith V Hobrath; Cecil D Kwong; Barbara E Laughon; Joseph A Maddry; Alka Mehta; Lynn Rasmussen; Robert C Reynolds; John A Secrist; Nice Shindo; Dustin N Showe; Melinda I Sosa; William J Suling; E Lucile White
Journal:  Tuberculosis (Edinb)       Date:  2009-09-15       Impact factor: 3.131

6.  Deleterious Consequences of UDP-Galactopyranose Mutase Inhibition for Nematodes.

Authors:  Valerie J Winton; Alexander M Justen; Helen Deng; Laura L Kiessling
Journal:  ACS Chem Biol       Date:  2017-08-16       Impact factor: 5.100

7.  Deciphering the sugar biosynthetic pathway and tailoring steps of nucleoside antibiotic A201A unveils a GDP-l-galactose mutase.

Authors:  Qinghua Zhu; Qi Chen; Yongxiang Song; Hongbo Huang; Jun Li; Junying Ma; Qinglian Li; Jianhua Ju
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

8.  The Search for Herbal Antibiotics: An In-Silico Investigation of Antibacterial Phytochemicals.

Authors:  Mary Snow Setzer; Javad Sharifi-Rad; William N Setzer
Journal:  Antibiotics (Basel)       Date:  2016-09-12

9.  Carboxylate Surrogates Enhance the Antimycobacterial Activity of UDP-Galactopyranose Mutase Probes.

Authors:  Valerie J Winton; Claudia Aldrich; Laura L Kiessling
Journal:  ACS Infect Dis       Date:  2016-06-29       Impact factor: 5.084

10.  First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.

Authors:  Terry K Smith; Benjamin L Young; Helen Denton; David L Hughes; Gerd K Wagner
Journal:  Bioorg Med Chem Lett       Date:  2009-01-30       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.